Advanced Search
MyIDEAS: Login

Protección de la Competencia en Chile: El Estado y Laboratorios Chile y Recalcine (1992-93)

Contents:

Author Info

  • Edgardo Barandiarán
  • Ricardo Paredes

Abstract

In 1992, Laboratorios Chile and Recalcine, the two largest pharmaceutical companies in Chile with a share of 82% of the domestic markets for generic products, were accused of collusion. The paper analyzes the process and the evidence considered by the Antitrust Commissions to assess the extent to which the Chilean system has been able to provide seguridad jurídica for market competition. Albeit economic models were readily available to argue the case, the process failed to generate the evidence necessary to apply them properly. The opposite decisions of the two Commissions reflected this failure and differences in the standards of proof. The analysis is useful, however, to understand the behavior and performance of the Chilean system of competition law.

Download Info

If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
File URL: http://www.economia.puc.cl/docs/dt_222.pdf
Download Restriction: no

Bibliographic Info

Paper provided by Instituto de Economia. Pontificia Universidad Católica de Chile. in its series Documentos de Trabajo with number 222.

as in new window
Length:
Date of creation: 2002
Date of revision:
Handle: RePEc:ioe:doctra:222

Contact details of provider:
Postal: Avda. Vicuña Mackenna 4860, Macul, Santiago
Phone: (562) 354-4303
Fax: (562) 553-1664
Email:
Web page: http://www.economia.puc.cl
More information through EDIRC

Related research

Keywords: Antitrust; collusion;

Find related papers by JEL classification:

References

References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
as in new window
  1. Dominique Demougin & Claude Fluet, 2002. "Preponderance of Evidence," CESifo Working Paper Series 725, CESifo Group Munich.
  2. F. M. Scherer, 1993. "Pricing, Profits, and Technological Progress in the Pharmaceutical Industry," Journal of Economic Perspectives, American Economic Association, vol. 7(3), pages 97-115, Summer.
Full references (including those not matched with items on IDEAS)

Citations

Lists

This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

Statistics

Access and download statistics

Corrections

When requesting a correction, please mention this item's handle: RePEc:ioe:doctra:222. See general information about how to correct material in RePEc.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Jaime Casassus).

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

If references are entirely missing, you can add them using this form.

If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

Please note that corrections may take a couple of weeks to filter through the various RePEc services.